Monographie - Acetylsalicylic acid lysinate

Senaste uppdateringen :
05/12/2025

Acetylsalicylic acid lysinate

Molekylstruktur

Varunamn

Angivna handelsnamn på läkemedel är enbart vägledande då formulering inklusive hjälpämnen kan variera mellan länder och tillverkare

Aspegic	Frankrike, Luxemburg, Marocko, Nederländerna, Portugal, Schweiz, Slovenien, Spanien, Tunisien
Inyesprin	Spanien
Kardegic	Frankrike
Laspal	Polen

Hänvisningar : Acetylsalicylic acid lysinate

	Typ	Publikation
1859	tidningen	Anacardio R, Perilli O, Pagnanelli F, Bartolini S, gentile MM, Mazzeo P, Carlucci G. Physicochemical compatibility between thiocolchicoside injections (Miotens®) and pharmaceutical products frequently used for combined therapy. Il Farmaco 2002 ; 57: 925-930.
2139	tidningen	Serrurier C, Chenot ED, Vigneron J, May I, Demor? B. Assessment of injectable drug’s administration in two intensive care units and determination of potential physico-chemical incompatibilities. EJHP Science 2006 ; 12,5: 96-99.
2212	Laboratorium	Reteplase (Rapilysin®) - Summary of Product Characteristics Actavis UK Ltd 2015
3838	Laboratorium	Magnesium Sulphate - Summary of Product Characteristics Martindale Pharmaceuticals Ltd 2007
4698	tidningen	Ayari G, D'Huart E, Vigneron J, Demoré B. Y-site compatibility of intravenous medications commonly used in intensive care units : laboratory tests on 75 mixtures involving nine main drugs. Pharmaceutical Technology in Hospital Pharmacy 2022 ; 7(1): 20220002
4951	Laboratorium	ACIDE ACETYLSALICYLIQUE PANPHARMA 1 g, poudre et solvant pour solution injectable - Résumé des caractéristiques du produit - Mise à jour 19/09/2024. PANMEDICA 2024

Mentions Légales